好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Discontinuation of Memantine Therapy in Nursing Home Residents with Alzheimer's Disease Is Associated with Increased Utilization of Psychotropic Medications and Decreased Body Weight
Aging and Dementia
(-)
184
Authors/Disclosures
Howard Fillit, MD (Alzheimer's Drug Discovery Foundation) No disclosure on file
No disclosure on file
Juliana Setyawan, PharmD, MS (Reata Pharmaceuticals, Inc) No disclosure on file
E Malca Resnick, PhD (Pfizer Inc) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Constantine Lyketsos (Johns Hopkins Medicine) Constantine Lyketsos has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Avanir, Karuna, Maplight, Axsome, GW Research Limited, Merck, EXCIVA GmbH, Otsuka, IntraCellular Therapies, Medesis, BMS, IQVIA. Constantine Lyketsos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. The institution of Constantine Lyketsos has received research support from NIA. Constantine Lyketsos has received publishing royalties from a publication relating to health care. Constantine Lyketsos has received publishing royalties from a publication relating to health care.
Sydney Cash, MD (Massachusetts General Hospital) Dr. Cash has received stock or an ownership interest from Beacon Biosignals.